Jun Liang

Active 1993–2026

662
Papers
39,764
Citations
104
h-index
463
i10-index

Citations

Citations per year for Jun Liang1966: 2 citations1989: 1 citations1991: 1 citations1995: 1 citations1996: 1 citations1997: 6 citations1998: 3 citations1999: 4 citations2000: 12 citations2001: 22 citations2002: 18 citations2003: 20 citations2004: 23 citations2005: 15 citations2006: 27 citations2007: 32 citations2008: 31 citations2009: 40 citations2010: 69 citations2011: 81 citations2012: 139 citations2013: 154 citations2014: 181 citations2015: 205 citations2016: 222 citations2017: 248 citations2018: 289 citations2019: 871 citations2020: 1,147 citations2021: 1,370 citations2022: 1,456 citations2023: 1,346 citations2024: 2,325 citations2025: 1,450 citations2026: 96 citations1967–1988: no citations, so these years are not shown1990: no citations, so this year is not shown1992–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,742 citing papers, 35.9% of this breakdownUnited States: 2,115 citing papers, 13.2% of this breakdownUnited Kingdom: 664 citing papers, 4.1% of this breakdownIndia: 481 citing papers, 3% of this breakdownGermany: 411 citing papers, 2.6% of this breakdownItaly: 391 citing papers, 2.4% of this breakdownSouth Korea: 391 citing papers, 2.4% of this breakdownJapan: 377 citing papers, 2.4% of this breakdownCanada: 347 citing papers, 2.2% of this breakdownFrance: 338 citing papers, 2.1% of this breakdownAustralia: 291 citing papers, 1.8% of this breakdownSpain: 269 citing papers, 1.7% of this breakdown
0%35.9%Other 26.2%

Fields

  • Medicine35.6%
  • Biochemistry, Genetics and Molecular Biology21.5%
  • Engineering14.4%
  • Computer Science9.3%
  • Immunology and Microbiology3.3%
  • Chemistry2.4%
  • Other13.5%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis2.1%
  • Mesenchymal stem cell research1.6%
  • Cancer Immunotherapy and Biomarkers1.2%
  • Advanced biosensing and bioanalysis techniques1.1%
  • Cancer-related molecular mechanisms research1%
  • Cholangiocarcinoma and Gallbladder Cancer Studies1%
  • Other92%

Coauthors

All papers

Open in search
  1. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linna Wang, Linna Wang, Ahmed O. Kaseb, Arndt Vogel, Shukui Qin, Shukui Qin, Shukui Qin, Ahmed O. Kaseb, Arndt Vogel, Shanzhi Gu, Arndt Vogel, Zhenggang Ren, Xiaoyan Lin, Zhenggang Ren, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Jianping Xiong, Wei Li, Yajin Chen, Yong Zeng, А. В. Султанбаев, Monika Pazgan−Simon, Margaryta Pisetska, Davide Melisi, Margaryta Pisetska, Yurii Osypchuk, Ivan Sinielnikov, Tsai‐Sheng Yang, Liang Xiao, Chunxia Chen, Linna Wang, Mingxiang Zhang, Li Xu, Xianglin Yuan, Da Li, Jierer Ying, Jingdong Zhang, Tao Zhang, Kangsheng Gu, Yifu He, Kangsheng Gu, Da Jiang, Shu Zhang, Baocai Xing, Baihong Zhang, Dong Wang, Xiaofeng Zhai, Houjie Liang, Bożena Cybulska-Stopa, Mikhail Dvorkin, Daniil Stroyakovskiy, M. Nechaeva, Chia‐Jui Yen, Wei‐Wen Su, Yen‐Hao Chen, Igor Bondarenko, Lin Yang, Weijia Fang, Carlos Gómez-Martín, Min‐Hee Ryu, Hansang Kim, Jeehyun Kim, Oleg Zarubenkov and 38 more - The Lancet 2023 cited by 679

  2. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 cited by 833

  3. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Ye‐Xiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Yang Jianyong, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhen‐Yu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Q. Li, Feng Shen, Shukui Qin, Gao‐Jun Teng and 2 more - Liver Cancer 2023 cited by 452

  4. Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hui Zhou, ORIENT-16 Investigators, Hongmei Sun, Qi Wang, Junhe Li, Da Jiang, Weijian Guo, Jieer Ying, Shubin Wang, Aimin Zang, Shirong Cai, Chunhong Hu, Tao Zhang, Min Tao, Jun Liang, Qinsheng Mao, Minghui Zhang, Rui Mao, Hui Yang, Hongyu Zhang, Lin Shen, Jin Lu, Wenxin Li, Yamin Chen, Lei Chen, Zhixiang Zhuang, Chunmei Bai, Heli Liu, Jingtang Chen, Wangjun Liao, Meng Qiu, Rongfeng Song, Man Li, S. B. Qian, Yunpeng Liu, Jiang Liu, Dong Wang, Xianli Yin, Zhiming Huang - JAMA 2023 cited by 357

  5. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shenghan Lai, Junhua Li, Guang Ning, Weiqing Wang - Nature Communications 2020 cited by 383

  6. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guoxin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Li Jin, Rui‐Hua Xu - Cancer Communications 2023 cited by 390

  7. CRISPR/Cas12a-based technology: A powerful tool for biosensing in food safety

    Authors: , , , , , , , , , , , , - Trends in Food Science & Technology 2022 cited by 170

  8. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lei Chen, Zhining Fan, Piaoyang Sun, Hao Yu - Journal of Clinical Oncology 2016 cited by 997

  9. Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 206

  10. VNAGT: Variational Non-Autoregressive Graph Transformer Network for Multi-Agent Trajectory Prediction

    Authors: , , , , - IEEE Transactions on Vehicular Technology, IEEE Trans. Veh. Technol. 2023 cited by 55

  11. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guoyue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiaoying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jian-qiang Cai, Wei–Lin Wang, Jiahong Dong, Qiang Li, Feng Shen, Shu-Kui Qin, Jia Fan - Liver Cancer 2018 cited by 688

  12. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut Microbes 2021 cited by 104

  13. A New Reaching Law for Antidisturbance Sliding-Mode Control of PMSM Speed Regulation System

    Authors: , , , - IEEE Transactions on Power Electronics 2019 cited by 386

  14. Effects of a commercial probiotic BS containing Bacillus subtilis and Bacillus licheniformis on growth, immune response and disease resistance in Nile tilapia, Oreochromis niloticus

    Authors: , , , , , , , , - Fish & Shellfish Immunology 2018 cited by 200

  15. How the public uses social media wechat to obtain health information in china: a survey study

    Authors: , , , - BMC Medical Informatics and Decision Making, BMC Medical Informatics Decis. Mak. 2017 cited by 438

  16. Richer fusion network for breast cancer classification based on multimodal data

    Authors: , , , , , , , , , , - BMC Medical Informatics and Decision Making, BMC Medical Informatics Decis. Mak. 2021 cited by 80

  17. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma

    Authors: , , , , , , , , , , - Molecular Cancer 2022 cited by 136

  18. Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma

    Authors: , , , , , , , , , , , - Cell Reports Medicine 2023 cited by 60

  19. T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy

    Authors: , , , - Frontiers in Immunology 2022 cited by 107

  20. Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial

    Authors: , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 cited by 72

  21. Systematic Evaluation of Research Progress on Natural Language Processing in Medicine Over the Past 20 Years: Bibliometric Study on PubMed

    Authors: , , , , , , , , - Journal of Medical Internet Research 2019 cited by 130

  22. Stochastic Non-Autoregressive Transformer-Based Multi-Modal Pedestrian Trajectory Prediction for Intelligent Vehicles

    Authors: , , , , - IEEE Transactions on Intelligent Transportation Systems, IEEE Trans. Intell. Transp. Syst. 2023 cited by 38

  23. Scallop genome provides insights into evolution of bilaterian karyotype and development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xianhui Ning, Yu Lin, Liang Zhao, Qiang Xing, Jinzhuang Dou, Yangping Li, Junxia Mao, Haobing Guo, Huaiqian Dou, Tianqi Li, Chuang Mu, Wenkai Jiang, Qiang Fu, Xiaoteng Fu, Yan Miao, Jian Liu, Qian Yu, Ruojiao Li, Huan Liao, Xuan Li, Yifan Kong, Zhi Jiang, Daniel Chourrout, Ruiqiang Li, Zhenmin Bao - Nature Ecology & Evolution 2017 cited by 466

  24. A Comprehensive Survey on VANET Security Services in Traffic Management System

    Authors: , - Wireless Communications and Mobile Computing, Wirel. Commun. Mob. Comput. 2019 cited by 179